FDA rethinks approach to testing new heartworm drugs

Cites evolving resistance of parasite

By: Lisa Wogan
For The VIN News Service 

The U.S. Food and Drug Administration is considering changing what it asks of drug makers to demonstrate efficacy of new heartworm preventive medications in dogs, in light of the parasite’s evolving resistance to drugs.